CCRL2 and breast cancer: DNA microarray data from 3951 breast cancer patients demonstrated that high mRNA expression of chemerin receptors CMKLR1 and GPR1 in tumor tissue was strongly associated with a longer RFS of breast cancer patients, whereas tissue expression of chemerin slightly decreased RFS and CCRL2 did not significantly affect patients’ survival.